We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Calithera Biosciences, Inc. (CALA - Free Report) was a big mover last session, as the company saw its shares rise over 17% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $10.85 to $14.30 in the past one-month time frame.
The company has seen one negative estimate revision in the last 30 days, while the Zacks Consensus Estimate moved higher suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
Currently, Calithera Biosciences carries a Zacks Rank #3 (Hold).
Is CALA going up? Or down? Predict to see what others think: Up or Down
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time. One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Calithera Biosciences (CALA) Jumps: Stock Moves 17% Higher
Calithera Biosciences, Inc. (CALA - Free Report) was a big mover last session, as the company saw its shares rise over 17% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $10.85 to $14.30 in the past one-month time frame.
The company has seen one negative estimate revision in the last 30 days, while the Zacks Consensus Estimate moved higher suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
Currently, Calithera Biosciences carries a Zacks Rank #3 (Hold).
Calithera Biosciences, Inc. Price
Calithera Biosciences, Inc. Price | Calithera Biosciences, Inc. Quote
A better-ranked stock in the same industry is MEI Pharma, Inc. (MEIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CALA going up? Or down? Predict to see what others think: Up or Down
Zacks' 2017 IPO Watch List
Before looking into the stocks mentioned above, you may want to get a head start on potential tech IPOs that are popping up on Zacks' radar. Imagine being in the first wave of investors to jump on a company with almost unlimited growth potential? This Special Report gives you the current scoop on 5 that may go public at any time. One has driven from 0 to a $68 billion valuation in 8 years. Four others are a little less obvious but already show jaw-dropping growth. Download this IPO Watch List today for free >>